Related Experiment Video
Updated: Jul 14, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Type I IFN contributes to NK cell homeostasis, activation, and antitumor function
Jeremy B Swann1, Yoshihiro Hayakawa, Nadeen Zerafa
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, 8006 Victoria, Australia.
Endogenous type I interferons (IFNs) are crucial for natural killer (NK) cell antitumor activity. This study shows type I IFNs regulate NK cell function and are vital for controlling tumor growth and immunotherapy effectiveness.
Area of Science:
- Immunology
- Cancer Biology
- Virology
Background:
- Type I interferons (IFNs) are critical immune modulators.
- Natural killer (NK) cells play a significant role in antitumor immunity.
Purpose of the Study:
- To investigate the role of endogenous type I IFNs in regulating NK cell antitumor responses.
- To determine the impact of type I IFNs on NK cell number, activation, and cytotoxic activity in various tumor models.
Main Methods:
- Utilized IFNAR1- and IFNAR2-deficient mice.
- Employed an IFNAR1-blocking antibody.
- Assessed NK cell-mediated antitumor activity in methylcholanthrene-induced sarcomas, RMA-S tumors, and lung metastasis models.
- Evaluated the efficacy of cytokine immunotherapy (IL-12, IL-18, IL-21, IL-2) in the absence of type I IFNs.
Main Results:
- Endogenous type I IFNs are critical regulators of NK cell numbers, activation, and antitumor functions across multiple experimental tumor models.
- Type I IFN-mediated protection against RMA-S tumors was more potent than that of other effector molecules like IFN-gamma, IL-12, IL-18, and perforin.
- Cytokine immunotherapies with IL-12, IL-18, and IL-21 remained effective without endogenous type I IFNs.
- The antimetastatic activity of IL-2 was significantly impaired in IFNAR-deficient mice due to defective IL-2-induced cytotoxicity.
Conclusions:
- Endogenous type I IFNs are central mediators of NK cell antitumor responses.
- Type I IFNs are essential for optimal NK cell function and efficacy in various cancer settings.
- Targeting type I IFN pathways could be a strategy to enhance NK cell-based cancer immunotherapies.
More Related Videos
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Type I Diabetes II: Pathophysiology

